ENTX
Entera Bio Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.94
+9.70%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-234.4%
Return on equity
-87.4%
Return on assets
-187.2%
Return on invested capital
0.00x
Asset turnover
-$11.3M
Cash from operations
$0.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026